RudaCure is a biotechnology company founded in 2018 that is developing treatments for incurable diseases with high unmet needs.Currently focusing on the development of two main assets (RCI001 & RCI002), with RCI001 being a treatment for Dry Eye Disease and RCI002 being a treatment for various pain diseases.